Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16457843 | 0.85 | TACR1 (0.45) | TP53 | |
| SCHEMBL29692948 | 0.80 | TAAR1 (0.46) | TAAR1IDO1ACHETP53MAPT | |
| Bisbenzyldiselenide SCHEMBL27490404 | 0.77 | CYP1A1 (0.50) | TAAR1IDO1TP53TSHRALOX12 | |
| Bisbenzyldiselenide SCHEMBL29169728 | 0.77 | CYP1A1 (0.56) | TAAR1IDO1TP53MAPTTSHR | |
| SCHEMBL3009700 | 0.76 | TAAR1 (0.65) | TAAR1IDO1ACHEHRH3MAOB | |
| SCHEMBL2938820 | 0.76 | CALM1 (0.57) | TAAR1IDO1ACHETP53CTBP2 | |
| SCHEMBL30674456 | 0.76 | CALM1 (0.57) | TAAR1IDO1ACHETP53CTBP2 | |
| SCHEMBL12506245 | 0.74 | TAAR1 (0.63) | TAAR1IDO1ACHEHRH3MAOB | |
| SCHEMBL8085716 | 0.74 | CALM1 (0.55) | TAAR1IDO1ACHETP53NPSR1 | |
| Diphenylmethane SCHEMBL3723822 | 0.73 | ACHE (0.60) | TAAR1IDO1ACHETP53NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133156-B2 | Method for preparing selenyl-substituted aromatic aldehyde compounds | SEJONG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (KR) | 2015-09-15 | — | — | US | disclosed |
| US-20140012021-A1 | NOVEL METHOD FOR PREPARING SELENYL-SUBSTITUTED AROMATIC ALDEHYDE COMPOUNDS | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (KR) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012021-A1 | NOVEL METHOD FOR PREPARING SELENYL-SUBSTITUTED AROMATIC ALDEHYDE COMPOUNDS | SELENOI, SCLY, AOX1 | TAAR1 1887/4885IDO1 2931/4885ACHE 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.